Delivery Order SPE2DB24D9238-SPE2DB25FDQVK
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency (DLA) on September 5, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 ml syringes, a prescription medication used in ophthalmic treatment. The order has an ultimate completion date of September 26, 2025, and carries no set-aside designation. This delivery order falls...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency on August 26, 2025. The delivery order covers VABYSMO 6 mg/0.05 mL syringes, a prescription pharmaceutical product, with an ultimate completion date of September 17, 2025. This award was not issued under a set-aside designation, allowing the vendor to compete directly in the open...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency (DLA) on August 14, 2025. The delivery order, which must be completed by September 5, 2025, covers the supply of VABYSMO 6 mg/0.05 ml syringes (0.05 ml units), an injectable pharmaceutical product. This award was issued without a set-aside designation, allowing the vendor to compete...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,224.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with a period of performance through April 2, 2024. This delivery order is issued against DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract SPE2DB, valued up to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $14,917.20 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order, which has an ultimate completion date of October 6, 2025, covers the supply of Vabysmo 6 mg/0.05 mL syringes for delivery to Park Ridge, Illinois. This award was issued without a set-aside designation, allowing the contractor to...
- The Defense Logistics Agency (DLA), functioning as part of the Department of Defense's Medical Supply Chain, awarded a delivery order valued at $8,655.50 to DMS Pharmaceutical Group Inc. for the supply of VABYSMO 6MG/0.05ML. This firm fixed-price delivery order, issued on June 25, 2025, with an ultimate completion date of the same day, represents a discrete pharmaceutical product delivery under DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA. The award was made...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,780.55, is for the supply of a single pharmaceutical product, VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with a performance period through July 5, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Vabysmo 6 mg/0.05 mL syringes valued at $4,475.16. The award, issued on July 31, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. This delivery order does not utilize a set-aside designation and represents a continuation of the...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,224.44 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with DLA under the SPE2DB program. The IDC enables DLA to issue delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $11,353.77 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on September 5, 2025, with completion expected by September 8, 2025. This delivery order carries no set-aside designation and represents work performed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at approximately...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDQVKDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,950.32 by the Defense Logistics Agency (DLA) on June 5, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 mL syringes, a pharmaceutical product used in ophthalmology treatment. This delivery order represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 vehicle that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies through firm fixed-price delivery orders. The contract is unencumbered by set-aside designations, and performance is slated for completion by June 27, 2025, at the company's Park Ridge, Illinois location. DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, consistently securing contracts with the DLA to support Department of Defense healthcare facilities nationwide. The company's portfolio encompasses an extensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, over-the-counter medications, and specialized medical consumables. This particular delivery order exemplifies the company's role in providing critical pharmaceutical products directly to military health facilities, reinforcing its positioning as a key vendor for the DLA's medical supply procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 6/5/25 |